» Articles » PMID: 34322514

Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis

Overview
Journal Front Nutr
Date 2021 Jul 29
PMID 34322514
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Weight loss by lifestyle modification is the cornerstone therapy of non-alcoholic fatty liver disease (NAFLD). Intermittent fasting has shown favorable effects on body weight (BW) and relevant indicators of NAFLD in several reports. To estimate the effects of intermittent fasting on adults with NAFLD. Literature searches were conducted on PubMed, EMBASE, Web of Science, Cochrane Library, and ClinicalTrials.gov from inception to May 10, 2021. A total of six studies involving 417 patients with NAFLD were included. In the meta-analysis, there were significant differences in BW, body mass index (BMI), alanine aminotransferase (ALT), and aspartate transaminase (AST) between the control and fasting group. Up to now, there is no significant difference in triglycerides (TG), total cholesterol (TC), and other metabolic parameters between the two groups. Intermittent fasting is beneficial for weight management and liver enzyme improvement, but long-term feasibility and safety of intermittent fasting should be conducted in further studies.

Citing Articles

Reshaping lipid metabolism with long-term alternate day feeding in type 2 diabetes mice.

Beli E, Yan Y, Moldovan L, Lydic T, Krishman P, Tersey S NPJ Metab Health Dis. 2025; 3(1):3.

PMID: 39911696 PMC: 11790504. DOI: 10.1038/s44324-024-00039-w.


Efficacy of intermittent fasting on improving liver function in individuals with metabolic disorders: a systematic review and meta-analysis.

Khalafi M, Rosenkranz S, Ghasemi F, Kheradmand S, Habibi Maleki A, Korivi M Nutr Metab (Lond). 2025; 22(1):1.

PMID: 39762987 PMC: 11706068. DOI: 10.1186/s12986-024-00885-x.


Effects of different types of intermittent fasting on metabolic outcomes: an umbrella review and network meta-analysis.

Chen Y, Tsai H, Tu Y, Chen L BMC Med. 2024; 22(1):529.

PMID: 39533312 PMC: 11559166. DOI: 10.1186/s12916-024-03716-1.


Night shift-induced circadian disruption: links to initiation of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and risk of hepatic cancer.

Singh A, Anjum B, Naz Q, Raza S, Sinha R, Ahmad M Hepatoma Res. 2024; .

PMID: 39525867 PMC: 7616786. DOI: 10.20517/2394-5079.2024.88.


Time-restricted feeding ameliorates non-alcoholic fatty liver disease through modulating hepatic nicotinamide metabolism via gut microbiota remodeling.

Feng R, Yang W, Feng W, Huang X, Cen M, Peng G Gut Microbes. 2024; 16(1):2390164.

PMID: 39154362 PMC: 11332628. DOI: 10.1080/19490976.2024.2390164.


References
1.
Connolly J, Romano T, Patruno M . Selections from current literature: effects of dieting and exercise on resting metabolic rate and implications for weight management. Fam Pract. 1999; 16(2):196-201. DOI: 10.1093/fampra/16.2.196. View

2.
Mari A, Khoury T, Baker M, Said Ahmad H, Abu Baker F, Mahamid M . The Impact of Ramadan Fasting on Fatty Liver Disease Severity: A Retrospective Case Control Study from Israel. Isr Med Assoc J. 2021; 23(2):94-98. View

3.
Varady K . Intermittent fasting is gaining interest fast. Nat Rev Mol Cell Biol. 2021; 22(9):587. DOI: 10.1038/s41580-021-00377-3. View

4.
Miele L, Targher G . Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications. Expert Rev Gastroenterol Hepatol. 2015; 9(10):1243-5. DOI: 10.1586/17474124.2015.1074860. View

5.
Ebrahimi S, Pourghassem Gargari B, Aliasghari F, Asjodi F, Izadi A . Ramadan fasting improves liver function and total cholesterol in patients with nonalcoholic fatty liver disease. Int J Vitam Nutr Res. 2019; 90(1-2):95-102. DOI: 10.1024/0300-9831/a000442. View